Immunic Inc (NAS:IMUX)
$ 1.03 -0.02 (-1.9%) Market Cap: 92.78 Mil Enterprise Value: 34.61 Mil PE Ratio: 0 PB Ratio: 2.25 GF Score: 42/100

Immunic Inc To Host Key Opinion Leaders Transcript

Jul 20, 2023 / 12:00PM GMT
Release Date Price: $2.54 (-4.15%)
Jessica Breu
Immunic, Inc. - Head of IR & Communications

All right. Let's kick this off. Good morning to everybody on the webcast. I would like to welcome you to our celiac disease roundtable table today. During the next approximately 1 hour, our experts will discuss why celiac disease is a serious lifelong autoimmune disorder and why there is a huge unmet medical need for new treatment options. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic. I will also be the moderator on today's webcast. (Operator Instructions)

After the expert discussion, you will also have an opportunity to questions. But let me first introduce today's experts. We are very excited to have had 3 renowned thought leaders in the area of celiac disease joining us. We warmly welcome Dr. Ciarán Kelly from the Harvard Medical School in Boston. Dr. Joseph Murray from the Mayo Clinic in Rochester, Minnesota and Marilyn Geller from the Celiac Foundation. From Immunic, we have our Chief Medical Officer, Dr. Andreas Muehler on the line. Thank you very much to all our experts for being with us

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot